{"id":60111,"date":"2024-02-28T06:34:29","date_gmt":"2024-02-28T06:34:29","guid":{"rendered":"https:\/\/medsname.com\/neurocetam\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"neurocetam","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/neurocetam\/","title":{"rendered":"Neurocetam"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Neurocetam?<\/h3>\n<p style=\"margin:0;\"><strong>Neurocetam<\/strong> este un <strong>comprimat<\/strong> care con\u021bin <strong>piracetam<\/strong> (400 mg) \u2014 derivatul original \u201cnootropic\u201d de tip pirolidon\u0103. Utilizat pentru: <strong>mioclonus cortical<\/strong> (indica\u021bia aprobat\u0103 de FDA\/EMA), <strong>declin cognitiv legat de v\u00e2rst\u0103<\/strong>, <strong>simptome cognitive dup\u0103 accident vascular cerebral sau traumatism cerebral<\/strong>, <strong>vertij de origine central\u0103<\/strong>, \u0219i <strong>dislexie la copii<\/strong> (indica\u021bie UE, al\u0103turi de remediere structurat\u0103). Dozaj pentru adul\u021bi: <strong>2,4\u20134,8 g\/zi<\/strong> \u00een 2\u20133 doze \u00eemp\u0103r\u021bite (cognitive); 7,2\u201324 g\/zi pentru mioclonus cortical. Se poate administra cu sau f\u0103r\u0103 alimente. \u00cencepere efect: 4\u20138 s\u0103pt\u0103m\u00e2ni pentru beneficii cognitive. \u00cen general bine tolerat; efecte secundare frecvente: insomnie, iritabilitate, cre\u0219tere \u00een greutate, cefalee. <strong>Contraindicated \u00een insuficien\u021b\u0103 renal\u0103 sever\u0103 \u0219i boala Huntington.<\/strong>. Neaprobat de FDA SUA \u2014 v\u00e2ndut ca medicament cu prescrip\u021bie \u00een majoritatea \u021b\u0103rilor din Europa, Asia \u0219i America Latin\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Neurocetam?<\/h2>\n<p>Neurocetam este un piracetam oral <strong>comprimat<\/strong> disponibil \u00een doze de 400 mg. Piracetamul (2-oxo-1-pirolidin\u0103 acetamid\u0103) este un derivat ciclic al GABA sintetizat de UCB \u00een 1964 \u0219i primul reprezentant al clasei <strong>clasei de nootropice racetam<\/strong>. Este autorizat \u00een majoritatea Europei, Americii Latine \u0219i Asiei ca medicament cu prescrip\u021bie pentru <strong>tulbur\u0103ri cognitive<\/strong>, <strong>mioclonus cortical<\/strong> \u0219i <strong>vertijului<\/strong>. Nu este aprobat de FDA \u00een Statele Unite, dar r\u0103m\u00e2ne utilizat pe scar\u0103 larg\u0103 la nivel interna\u021bional.<\/p>\n<p>Neurocetam este furnizat de un produc\u0103tor certificat WHO-GMP \u0219i este bioechivalent cu piracetamul de marc\u0103 original\u0103 (Nootropil\u00ae, UCB).<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Neurocetam?<\/h2>\n<p>Mecanismul piracetamului este neobi\u0219nuit \u0219i incomplet \u00een\u021beles dup\u0103 60 de ani de utilizare clinic\u0103:<\/p>\n<ul>\n<li><strong>Modularea fluidit\u0103\u021bii membranare<\/strong> \u2014 piracetamul interac\u021bioneaz\u0103 cu grupurile head ale fosfolipidelor, restabilind fluiditatea membranar\u0103 \u00een neuronii \u00eemb\u0103tr\u00e2ni\u021bi sau deteriora\u021bi. Acest lucru poate explica efectul s\u0103u preferen\u021bial \u00een popula\u021biile cu deficien\u021be cognitive, nu \u00een cele s\u0103n\u0103toase.<\/li>\n<li><strong>\u00cembun\u0103t\u0103\u021birea microcircula\u021biei cerebrale<\/strong> \u2014 reduce rigiditatea eritrocitelor \u0219i agregarea plachetelor, \u00eembun\u0103t\u0103\u021bind modest fluxul sanguin cerebral f\u0103r\u0103 a modifica tensiunea arterial\u0103 sistemic\u0103.<\/li>\n<li><strong>Modularea receptorilor AMPA<\/strong> \u2014 efect alosteric pozitiv asupra receptorilor de glutamat AMPA, sporind poten\u021bierea pe termen lung \u00een modele animale.<\/li>\n<li><strong>\u00cembun\u0103t\u0103\u021bire colinergic\u0103<\/strong> \u2014 cre\u0219terea capt\u0103rii de colin\u0103 cu afinitate ridicat\u0103 \u0219i sinteza de acetilcolin\u0103 \u00een unele regiuni cerebrale.<\/li>\n<li><strong>Protec\u021bie mitochondrial\u0103<\/strong> \u2014 p\u0103streaz\u0103 produc\u021bia de ATP \u00een condi\u021bii de stres hipoxic.<\/li>\n<\/ul>\n<p>Spre deosebire de anticonvulsivantele sedative, piracetamul nu are <strong>activitate la receptorii GABA, nu are ac\u021biune sedativ\u0103, nu prezint\u0103 poten\u021bial de dependen\u021b\u0103<\/strong> \u0219i nu provoac\u0103 obtuzitate cognitiv\u0103. Este \u00een general inactiv la adul\u021bii tineri s\u0103n\u0103to\u0219i \u0219i produce beneficii mai evidente la pacien\u021bii cu deficien\u021be cognitive, boli vasculare cerebrale sau mioclonus cortical.<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<ul>\n<li><strong>Mioclonus cortical<\/strong> \u2014 cea mai solid\u0103 baz\u0103 de dovezi; piracetamul este un tratament recunoscut, adesea ca adjuvant altor anticonvulsivante<\/li>\n<li><strong>Deteriorarea cognitiv\u0103 legat\u0103 de v\u00e2rst\u0103<\/strong> \u2014 deficien\u021b\u0103 cognitiv\u0103 u\u0219oar\u0103, deficien\u021b\u0103 cognitiv\u0103 vascular\u0103<\/li>\n<li><strong>Recuperarea cognitiv\u0103 post-AVC<\/strong> \u2014 \u00een special afazia dup\u0103 accident vascular cerebral hemisferic st\u00e2ng (indica\u021bie UE; unele studii randomizate confirm\u0103)<\/li>\n<li><strong>Sechelele cognitive ale traumatismului cranio-cerebral<\/strong><\/li>\n<li><strong>Vertij de origine central\u0103<\/strong> \u2014 \u00eembun\u0103t\u0103\u021be\u0219te compensarea vestibular\u0103<\/li>\n<li><strong>Dislexia la copii &gt;7 ani<\/strong> \u2014 indica\u021bie UE, utilizat ca adjuvant la remedierea structurat\u0103<\/li>\n<li><strong>Prevenirea crizelor de anemie falciform\u0103<\/strong> \u2014 off-label, mecanismul este efectul reologic asupra eritrocitelor<\/li>\n<li><strong>Off-label:<\/strong> nootropic general \/ \u00eembun\u0103t\u0103\u021bire cognitiv\u0103 (dovezi limitate la adul\u021bii tineri s\u0103n\u0103to\u0219i)<\/li>\n<\/ul>\n<p>Neurocetam este <strong>prime\u0219te,<\/strong> de prim\u0103 inten\u021bie pentru: demen\u021ba Alzheimer (inhibitorii de colinesteraz\u0103 \u0219i memantina au dovezi mai solide), depresia cu simptome cognitive (trata\u021bi \u00eent\u00e2i depresia) sau tulburarea de deficit de aten\u021bie.<\/p>\n<h2 class=\"wp-block-heading\">Doza Neurocetam \u0219i modul de administrare<\/h2>\n<p>Concentra\u021bii Neurocetam: <strong>400 mg<\/strong>.<\/p>\n<p><strong>Doze standard pentru adul\u021bi pe indica\u021bie:<\/strong><\/p>\n<ul>\n<li><strong>Deteriorare cognitiv\u0103 legat\u0103 de v\u00e2rst\u0103 \/ demen\u021b\u0103 vascular\u0103 \/ post-accident vascular cerebral:<\/strong> 2,4\u20134,8 g\/zi \u00een 2\u20133 doze divizate. Mul\u021bi pacien\u021bi r\u0103spund la 2,4 g\/zi (de ex. 800 mg de trei ori pe zi).<\/li>\n<li><strong>Mioclonie cortical\u0103:<\/strong> \u00cencepe\u021bi cu 7,2 g\/zi \u00een 2\u20133 doze. Cre\u0219te\u021bi cu 4,8 g\/zi la fiecare 3\u20134 zile p\u00e2n\u0103 la un maxim de 24 g\/zi. Doza de \u00eentre\u021binere este cea mai mic\u0103 doz\u0103 care controleaz\u0103 miocloniile.<\/li>\n<li><strong>Vertij:<\/strong> 2,4\u20134,8 g\/zi \u00een 2\u20133 doze timp de 8\u201312 s\u0103pt\u0103m\u00e2ni; reevalua\u021bi.<\/li>\n<li><strong>Copii cu dislexie (&gt;7 ani):<\/strong> 3,2 g\/zi \u00een 2 doze divizate, al\u0103turi de educa\u021bie remedial\u0103 structurat\u0103.<\/li>\n<li><strong>Afectare renal\u0103:<\/strong> ajustarea dozei \u00een func\u021bie de clearance-ul de creatinin\u0103 \u2014 CrCl 50\u201379: doz\u0103 standard; CrCl 30\u201349: jum\u0103tate de doz\u0103; CrCl &lt;30: nu este recomandat.<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">Cum s\u0103 lua\u021bi Neurocetam corect<\/h3>\n<ol>\n<li><strong>De dou\u0103 p\u00e2n\u0103 la trei ori pe zi, la intervale egale.<\/strong> Timpul de \u00eenjum\u0103t\u0103\u021bire este de 4\u20135 ore. Intervalele de dozare sunt importante pentru mioclonie; mai pu\u021bin critice pentru utilizarea cognitiv\u0103.<\/li>\n<li><strong>Cu sau f\u0103r\u0103 alimente.<\/strong> Alimentele \u00eent\u00e2rzie u\u0219or absorb\u021bia, dar nu reduc cantitatea total\u0103 absorbit\u0103.<\/li>\n<li><strong>Permite\u021bi 4\u20138 s\u0103pt\u0103m\u00e2ni la doza terapeutic\u0103<\/strong> \u00eenainte de a evalua beneficiul cognitiv. Efectele se acumuleaz\u0103 treptat, mai degrab\u0103 dec\u00e2t s\u0103 produc\u0103 o schimbare acut\u0103 \u00een claritatea mintal\u0103.<\/li>\n<li><strong>Pentru mioclonie cortical\u0103, titra\u021bi treptat pe o perioad\u0103 de 1\u20132 s\u0103pt\u0103m\u00e2ni<\/strong> p\u00e2n\u0103 la ob\u021binerea controlului adecvat. Dozele de 16\u201324 g\/zi sunt adesea necesare \u0219i bine tolerate.<\/li>\n<li><strong>Evita\u021bi administrarea la ora de culcare<\/strong> dac\u0103 sunte\u021bi predispus la insomnie \u2014 piracetamul poate avea un efect u\u0219or activant.<\/li>\n<li><strong>Spune\u021bi fiec\u0103rui medic prescriptor.<\/strong> Interac\u021biunea cu hormonul tiroidian este singura relevant\u0103 din punct de vedere clinic comun.<\/li>\n<li><strong>\u00centreruperea este simpl\u0103 \u00een majoritatea cazurilor \u2014 nu exist\u0103 un protocol specific de reducere treptat\u0103<\/strong> pentru utilizarea cognitiv\u0103. Pentru mioclonie cortical\u0103, reduce\u021bi treptat sub supraveghere specializat\u0103 pentru a evita reapari\u021bia miocloniei.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Efecte secundare ale Neurocetam<\/h2>\n<p><strong>Comune (adesea legate de doz\u0103, deseori u\u0219oare):<\/strong><\/p>\n<ul>\n<li>Insomnie, agita\u021bie u\u0219oar\u0103<\/li>\n<li>Iritabilitate, hiperkinez\u0103 (\u00een special la adul\u021bii \u00een v\u00e2rst\u0103 \u0219i copii)<\/li>\n<li>Dureri de cap<\/li>\n<li>Cre\u0219tere \u00een greutate (~5% dintre pacien\u021bi)<\/li>\n<li>Diaree<\/li>\n<li>Somnolen\u021b\u0103 (paradoxal\u0103, mai pu\u021bin frecvent\u0103 dec\u00e2t insomnia)<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente, dar importante:<\/strong><\/p>\n<ul>\n<li>Modific\u0103ri ale st\u0103rii de spirit, anxietate, depresie (rare)<\/li>\n<li>Ame\u021beli<\/li>\n<li>Astenie<\/li>\n<li>Tulbur\u0103ri sexuale (rare)<\/li>\n<li>Tendin\u021b\u0103 crescut\u0103 de s\u00e2ngerare \u2014 piracetam inhib\u0103 u\u0219or agregarea plachetelor<\/li>\n<\/ul>\n<p><strong>Rare dar necesita aten\u021bie medical\u0103:<\/strong><\/p>\n<ul>\n<li>Eruptie cutanat\u0103 sever\u0103 sau angioedem (hipersensibilitate)<\/li>\n<li>\u00cenr\u0103ut\u0103\u021birea coreei Huntington preexistente<\/li>\n<li>Evenimente hemoragice severe la pacien\u021bii cu tulbur\u0103ri de s\u00e2ngerare sau sub tratament anticoagulant<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Avertismente \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Afectare renal\u0103:<\/strong> piracetam este eliminat 100% prin rinichi. Ajusta\u021bi doza \u00een func\u021bie de clearance-ul de creatinin\u0103; evita\u021bi la CrCl &lt;30 mL\/min.<\/li>\n<li><strong>Tendin\u021b\u0103 de s\u00e2ngerare:<\/strong> piracetam inhib\u0103 agregarea plachetelor. Precau\u021bie la pacien\u021bii cu ulcer peptic, hemoragii severe, interven\u021bii chirurgicale recente, sub tratament anticoagulant sau antiagregant plachetar.<\/li>\n<li><strong>Boala Huntington:<\/strong> evita\u021bi \u2014 piracetamul poate agrava coreea la unii pacien\u021bi.<\/li>\n<li><strong>V\u00e2rstnici:<\/strong> hipercinezii, agita\u021bia \u0219i insomnia sunt mai frecvente; \u00eencepe\u021bi cu doza minim\u0103 din intervalul recomandat.<\/li>\n<li><strong>Sarcina:<\/strong> siguran\u021ba nu a fost stabilit\u0103. Evita\u021bi cu excep\u021bia cazului \u00een care beneficiul dep\u0103\u0219e\u0219te clar riscul necunoscut \u2014 utiliza\u021bi numai sub \u00eendrumare specializat\u0103.<\/li>\n<li><strong>Al\u0103ptarea:<\/strong> piracetamul este excretat \u00een laptele matern; evita\u021bi sau \u00eentrerupe\u021bi al\u0103ptarea.<\/li>\n<li><strong>Interven\u021bii chirurgicale programate:<\/strong> \u00eentrerupe\u021bi piracetamul cu 1 s\u0103pt\u0103m\u00e2n\u0103 \u00eenainte de interven\u021bie dac\u0103 este posibil, datorit\u0103 efectului asupra plachetelor sanguine.<\/li>\n<li><strong>Conducere:<\/strong> apare ocazional somnolen\u021b\u0103; evita\u021bi conducerea p\u00e2n\u0103 c\u00e2nd \u0219ti\u021bi cum v\u0103 afecteaz\u0103 medicamentul.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii \u2014 Cine NU ar trebui s\u0103 ia Neurocetam<\/h2>\n<ul>\n<li>Hipersensibilitate cunoscut\u0103 la piracetam, deriva\u021bi de pirrolidon\u0103 sau orice excipient<\/li>\n<li>Insuficien\u021b\u0103 renal\u0103 \u00een stadiu terminal (CrCl &lt;20 mL\/min<\/li>\n<li>Hemoragie cerebral\u0103 (acut\u0103)<\/li>\n<li>Boala Huntington<\/li>\n<li>Sarcina \u0219i al\u0103ptarea (cu excep\u021bia cazurilor \u00een care specialistul consider\u0103 c\u0103 beneficiul dep\u0103\u0219e\u0219te riscul)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Combina\u021bi cu<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Efect<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Ce s\u0103 face\u021bi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Hormon tiroidian (tiroxin\u0103, T3)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cazuri raportate de confuzie, tremor \u0219i tulbur\u0103ri de somn<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Utiliza\u021bi cu precau\u021bie; observa\u021bi simptome asem\u0103n\u0103toare celor adrenergice.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Warfarin sau alte anticoagulante<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tendin\u021b\u0103 aditiv\u0103 de s\u00e2ngerare (piracetam inhib\u0103 u\u0219or plachetele)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitoriza\u021bi INR sau s\u00e2nger\u0103rile; piracetamul singur nu prelunge\u0219te INR, dar poate agrava s\u00e2nger\u0103rile cauzate de anticoagulante.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Aspirin\u0103, AINS, antiagregante plaquetare<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Efect antiagregant aditiv<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Precau\u021bie; evita\u021bi combina\u021bia la pacien\u021bii cu antecedente de s\u00e2nger\u0103ri.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alcool<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Nicio interac\u021biune farmacocinetic\u0103 semnificativ\u0103; efecte CNS aditive minime.<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u00cen general sigur \u00een consum moderat.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Al\u021bi agen\u021bi modulatori AMPA<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Efecte aditive teoretice<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Supraveghere specializat\u0103.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Carbamazepin\u0103, fenitoin\u0103, valproat de sodiu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Nicio interac\u021biune semnificativ\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Utilizate \u00eempreun\u0103 pentru sindroame mioclonice.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Instruc\u021biuni de Depozitare<\/h2>\n<ul>\n<li>Se p\u0103streaz\u0103 la temperatura camerei, <strong>15\u201330\u00b0C<\/strong>. Proteja\u021bi de umiditate.<\/li>\n<li>P\u0103stra\u021bi comprimatele \u00een ambalajul original blister p\u00e2n\u0103 la utilizare.<\/li>\n<li>Nu depozita\u021bi \u00een baie.<\/li>\n<li>P\u0103stra\u021bi la distan\u021b\u0103 de copii.<\/li>\n<li>Nu utiliza\u021bi dup\u0103 data de expirare.<\/li>\n<li>Returna\u021bi medicamentele neutilizate la farmacie pentru eliminare corespunz\u0103toare.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Alternative conexe pe MedsBase<\/h2>\n<p>Alte medicamente disponibile pentru afec\u021biuni conexe:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/neurological-conditions-and-epilepsy\/\">R\u0103sfoi\u021bi toate medicamentele neurologice \u0219i antiepileptice<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/anti-migraine\/\">R\u0103sfoi\u021bi medicamentele anti-migren\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/mental-health-and-psychiatric-medications\/\">R\u0103sfoi\u021bi medicamentele pentru s\u0103n\u0103tatea mintal\u0103 \u0219i psihiatrie<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2t dureaz\u0103 p\u00e2n\u0103 \u00eencepe s\u0103 ac\u021bioneze Neurocetam?<\/h3>\n<p><strong>Beneficiile cognitive se acumuleaz\u0103 treptat pe parcursul a 4\u20138 s\u0103pt\u0103m\u00e2ni<\/strong> la doza terapeutic\u0103 \u2014 acesta nu este un medicament care produce o \u00eembun\u0103t\u0103\u021bire acut\u0103 a clarit\u0103\u021bii mentale \u00een c\u00e2teva ore. Pentru <strong>mioclonus cortical<\/strong>, r\u0103spunsul poate fi observat \u00een 1\u20132 s\u0103pt\u0103m\u00e2ni odat\u0103 ce doza atinge intervalul terapeutic (de obicei 7,2\u201324 g\/zi). Pentru <strong>afazie post-accident vascular cerebral<\/strong>, beneficiul apare progresiv \u00een 6\u201312 s\u0103pt\u0103m\u00e2ni al\u0103turi de terapia de limbaj. Dac\u0103 nu se observ\u0103 nicio \u00eembun\u0103t\u0103\u021bire dup\u0103 8 s\u0103pt\u0103m\u00e2ni, este indicat\u0103 cre\u0219terea dozei sau terapie alternativ\u0103.<\/p>\n<h3 class=\"wp-block-heading\">De ce Neurocetam nu este aprobat de FDA \u00een SUA?<\/h3>\n<p>Piracetamul a fost dezvoltat \u00een Belgia \u00een anii 1960 \u0219i este autorizat \u00een Europa, Asia \u0219i America Latin\u0103 de zeci de ani. De\u021bin\u0103torul brevetului nu a solicitat niciodat\u0103 aprobarea FDA \u00een Statele Unite \u2014 par\u021bial pentru c\u0103 costurile de dezvoltare nu ar fi fost recuperate, av\u00e2nd \u00een vedere c\u0103 piracetamul a ie\u0219it de sub protec\u021bia brevetului \u00eenainte ca procesul modern de aprobare FDA s\u0103 se consolideze, \u0219i par\u021bial pentru c\u0103 criteriile de evaluare pentru \u00eembun\u0103t\u0103\u021birea cognitiv\u0103 nu erau bine definite la acea vreme. Medicamentul r\u0103m\u00e2ne un produs farmaceutic recunoscut, cu date ample de siguran\u021b\u0103 pe termen lung pe pie\u021bele unde este autorizat.<\/p>\n<h3 class=\"wp-block-heading\">Este Neurocetam un adev\u0103rat \u201cnootropic\u201d?<\/h3>\n<p><strong>Piracetamul este medicamentul original pentru care termenul \u201cnootropic\u201d a fost inventat<\/strong> de co-descoperitorul s\u0103u, Corneliu Giurgea, \u00een 1972. Defini\u021bia original\u0103 impunea: \u00eembun\u0103t\u0103\u021birea \u00eenv\u0103\u021b\u0103rii\/memoriz\u0103rii, protec\u021bie \u00eempotriva deterior\u0103rii, toxicitate foarte sc\u0103zut\u0103, absen\u021ba efectelor sedative sau stimulante \u0219i lipsa efectelor secundare farmacologice tipice. Piracetamul \u00eendepline\u0219te aceste criterii. \u00cen utilizarea contemporan\u0103, termenul \u201cnootropic\u201d a fost aplicat multor suplimente f\u0103r\u0103 dovezi comparabile; piracetamul r\u0103m\u00e2ne \u00eentr-o categorie separat\u0103, ca medicament de prescrip\u021bie reglementat.<\/p>\n<h3 class=\"wp-block-heading\">Func\u021bioneaz\u0103 Neurocetam pentru adul\u021bii tineri s\u0103n\u0103to\u0219i care doresc \u00eembun\u0103t\u0103\u021bire cognitiv\u0103?<\/h3>\n<p><strong>Dovezile sunt cele mai slabe \u00een acest grup.<\/strong> Majoritatea studiilor clinice au fost efectuate la adul\u021bi \u00een v\u00e2rst\u0103, pacien\u021bi post-AVC sau pacien\u021bi cu deficien\u021be cognitive \u2014 popula\u021bii \u00een care piracetamul arat\u0103 beneficii mai clare. La adul\u021bii tineri \u0219i s\u0103n\u0103to\u0219i, studiile controlate sunt rare, iar efectul, dac\u0103 exist\u0103, este modest. Piracetamul nu este un substitut pentru somn, exerci\u021biu fizic, hidratare sau medicamente stimulante atunci c\u00e2nd acestea sunt indicate.<\/p>\n<h3 class=\"wp-block-heading\">Care este diferen\u021ba dintre piracetam \u0219i alte racetame?<\/h3>\n<p><strong>Piracetam<\/strong> este racetam-ul original \u2014 cea mai sc\u0103zut\u0103 poten\u021b\u0103, cele mai multe dovezi, cel mai lung istoric de siguran\u021b\u0103. <strong>Aniracetam<\/strong> este liposolubil, ac\u021bioneaz\u0103 mai rapid, u\u0219or mai anxiolitic; <strong>oxiracetam<\/strong> este mai stimulant; <strong>levetiracetam<\/strong> este un anticonvulsivant structural \u00eenrudit cu o farmacologie foarte diferit\u0103 \u0219i aprobat de FDA; <strong>brivaracetam<\/strong> este un anticonvulsivant mai nou pentru crize focale. Dintre acestea, doar piracetam \u0219i levetiracetam au dovezi clinice umane substan\u021biale; celelalte sunt utilizate \u00een principal off-label sau ca suplimente.<\/p>\n<h3 class=\"wp-block-heading\">Interac\u021bioneaz\u0103 Neurocetam cu medicamentele pentru tiroid\u0103?<\/h3>\n<p><strong>Exist\u0103 rapoarte de caz<\/strong> de confuzie, tremor \u0219i tulbur\u0103ri de somn atunci c\u00e2nd piracetamul este combinat cu tiroxin\u0103 sau T3, suger\u00e2nd o posibil\u0103 interac\u021biune de tip adrenergic. Mecanismul nu este \u00een\u021beles. Dac\u0103 sunte\u021bi sub tratament cu hormon tiroidian, informa\u021bi medicul \u00eenainte de a \u00eencepe piracetamul, observa\u021bi prezen\u021ba tremorului, anxiet\u0103\u021bii sau tulbur\u0103rilor de somn \u0219i reduce\u021bi doza de piracetam dac\u0103 apar simptome.<\/p>\n<h3 class=\"wp-block-heading\">Neurocetam provoac\u0103 cre\u0219tere \u00een greutate?<\/h3>\n<p><strong>O u\u0219oar\u0103 cre\u0219tere \u00een greutate este raportat\u0103 la aproximativ 5% dintre pacien\u021bi<\/strong>, mai frecvent la adul\u021bii \u00een v\u00e2rst\u0103 \u0219i la doze mai mari (8 g\/zi sau mai mult). Mecanismul nu este clar \u00een\u021beles. Efectul este reversibil la reducerea dozei sau la \u00eentreruperea administr\u0103rii.<\/p>\n<h3 class=\"wp-block-heading\">Poate fi folosit Neurocetam la copii?<\/h3>\n<p><strong>Da \u2014 piracetamul este autorizat \u00een Europa pentru dislexia la copii &gt;7 ani<\/strong> ca adjuvant la educa\u021bia remedial\u0103 structurat\u0103. Doza tipic\u0103 este de 3,2 g\/zi \u00een 2 doze \u00eemp\u0103r\u021bite. Este utilizat \u0219i \u00een mioclonia cortical\u0103 pediatric\u0103 \u0219i \u00een sechelele cognitive post-traumatice. Hipercinezia \u0219i iritabilitatea sunt u\u0219or mai frecvente la copii; observa\u021bia parental\u0103 atent\u0103 este recomandabil\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Neurocetam este addictiv?<\/h3>\n<p><strong>Nu.<\/strong> Piracetamul nu are activitate la receptorii GABA, nu are activitate opioid\u0103, nu are ac\u021biune stimulant\u0103 \u0219i nu are poten\u021bial documentat de toleran\u021b\u0103 sau dependen\u021b\u0103. Poate fi \u00eentrerupt f\u0103r\u0103 o reducere gradual\u0103 structurat\u0103 pentru indica\u021biile cognitive, de\u0219i pentru mioclonia cortical\u0103 o reducere gradual\u0103 este recomandabil\u0103 pentru a evita simptomele de revenire.<\/p>\n<h3 class=\"wp-block-heading\">Pot consuma alcool \u00een timp ce iau Neurocetam?<\/h3>\n<p><strong>Da, cu modera\u021bie.<\/strong> Nu exist\u0103 o interac\u021biune farmacocinetic\u0103 specific\u0103 \u0219i nici un risc aditiv documentat. Consumul excesiv de alcool r\u0103m\u00e2ne d\u0103un\u0103tor cogni\u021biei independent. Unii pacien\u021bi folosesc piracetam off-label dup\u0103 intoxica\u021bia acut\u0103 pe teoria c\u0103 \u00eembun\u0103t\u0103\u021be\u0219te recuperarea; dovezile pentru aceast\u0103 utilizare sunt limitate.<\/p>\n<h3 class=\"wp-block-heading\">Unde este fabricat Neurocetam?<\/h3>\n<p>Neurocetam este furnizat de un <strong>produc\u0103tor certificat WHO-GMP<\/strong> \u0219i este bioechivalent cu piracetamul de marc\u0103 original\u0103 (Nootropil\u00ae, UCB) la aceea\u0219i concentra\u021bie \u00een miligrame. Certificatele de analiz\u0103 ale lotului sunt disponibile la cerere.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/omnacortil\/\">Omnacortil<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tenvir-af\/\">Tenvir AF<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/healmaryl\/\">Healmaryl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glinil-m\/\">Glinil M<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/beloc\/\">Beloc<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u00cembun\u0103t\u0103\u021be\u0219te func\u021bia cognitiv\u0103<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te retin\u021bia memoriei<br \/>\n\u2705 Spore\u0219te claritatea mintal\u0103<br \/>\n\u2705 Cre\u0219te concentrarea \u0219i vigilen\u021ba<br \/>\n\u2705 Sus\u021bine s\u0103n\u0103tatea creierului<\/p>\n<p>Neurocetam con\u021bine Piracetam.<\/p>","protected":false},"featured_media":60112,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3468],"product_tag":[4812,4800],"class_list":{"0":"post-60111","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-neurological-conditions-and-epilepsy","9":"product_tag-neurocetam","10":"product_tag-piracetam","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/60111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=60111"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/60112"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=60111"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=60111"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=60111"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=60111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}